Thomas Bohnacker

1.2k total citations
23 papers, 889 citations indexed

About

Thomas Bohnacker is a scholar working on Molecular Biology, Immunology and Organic Chemistry. According to data from OpenAlex, Thomas Bohnacker has authored 23 papers receiving a total of 889 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 8 papers in Immunology and 6 papers in Organic Chemistry. Recurrent topics in Thomas Bohnacker's work include PI3K/AKT/mTOR signaling in cancer (15 papers), Mast cells and histamine (7 papers) and Quinazolinone synthesis and applications (3 papers). Thomas Bohnacker is often cited by papers focused on PI3K/AKT/mTOR signaling in cancer (15 papers), Mast cells and histamine (7 papers) and Quinazolinone synthesis and applications (3 papers). Thomas Bohnacker collaborates with scholars based in Switzerland, United Kingdom and Germany. Thomas Bohnacker's co-authors include Matthias P. Wymann, Romina Marone, Florent Beaufils, Anna Melone, Denise Rageot, Doriano Fabbro, Alexander Sele, Petra Hillmann, Paul Hebeisen and Chiara Borsari and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and PLoS ONE.

In The Last Decade

Thomas Bohnacker

22 papers receiving 868 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas Bohnacker Switzerland 16 624 198 177 138 103 23 889
Vladimir Cmiljanović Switzerland 6 614 1.0× 101 0.5× 142 0.8× 119 0.9× 120 1.2× 15 794
Da-Sheng Wang United States 12 696 1.1× 181 0.9× 68 0.4× 195 1.4× 133 1.3× 13 1.1k
Danny Tam United States 14 449 0.7× 77 0.4× 119 0.7× 84 0.6× 144 1.4× 25 870
Anice Moumen France 13 333 0.5× 49 0.2× 92 0.5× 86 0.6× 79 0.8× 15 680
Philip Ryan United States 14 514 0.8× 110 0.6× 83 0.5× 51 0.4× 159 1.5× 23 824
Martin Pass United Kingdom 16 551 0.9× 69 0.3× 212 1.2× 62 0.4× 250 2.4× 31 873
Wells S. Brown United States 15 552 0.9× 121 0.6× 89 0.5× 98 0.7× 266 2.6× 24 895
Kenneth R. LaMontagne United States 14 751 1.2× 157 0.8× 55 0.3× 52 0.4× 273 2.7× 21 1.1k
Joachim Bischof Germany 15 587 0.9× 42 0.2× 73 0.4× 50 0.4× 210 2.0× 33 826
Arabel Vollmann‐Zwerenz Germany 15 459 0.7× 131 0.7× 49 0.3× 182 1.3× 240 2.3× 24 881

Countries citing papers authored by Thomas Bohnacker

Since Specialization
Citations

This map shows the geographic impact of Thomas Bohnacker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Bohnacker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Bohnacker more than expected).

Fields of papers citing papers by Thomas Bohnacker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Bohnacker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Bohnacker. The network helps show where Thomas Bohnacker may publish in the future.

Co-authorship network of co-authors of Thomas Bohnacker

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Bohnacker. A scholar is included among the top collaborators of Thomas Bohnacker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Bohnacker. Thomas Bohnacker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Keleş, Erhan, Luka Raguž, Thorsten Schaefer, et al.. (2024). Rapid, potent, and persistent covalent chemical probes to deconvolute PI3Kα signaling. Chemical Science. 15(48). 20274–20291. 1 indexed citations
2.
3.
Gogvadze, Elena, et al.. (2020). PI3Kγ Regulatory Protein p84 Determines Mast Cell Sensitivity to Ras Inhibition—Moving Towards Cell Specific PI3K Targeting?. Frontiers in Immunology. 11. 585070–585070. 10 indexed citations
4.
Borsari, Chiara, Denise Rageot, Thomas Bohnacker, et al.. (2019). A Conformational Restriction Strategy for the Identification of a Highly Selective Pyrimido-pyrrolo-oxazine mTOR Inhibitor. Journal of Medicinal Chemistry. 62(18). 8609–8630. 30 indexed citations
5.
Rageot, Denise, Thomas Bohnacker, Erhan Keleş, et al.. (2019). (S)-4-(Difluoromethyl)-5-(4-(3-methylmorpholino)-6-morpholino-1,3,5-triazin-2-yl)pyridin-2-amine (PQR530), a Potent, Orally Bioavailable, and Brain-Penetrable Dual Inhibitor of Class I PI3K and mTOR Kinase. Journal of Medicinal Chemistry. 62(13). 6241–6261. 49 indexed citations
6.
Gangadhara, Gangadhara, Göran Dahl, Thomas Bohnacker, et al.. (2019). A class of highly selective inhibitors bind to an active state of PI3Kγ. Nature Chemical Biology. 15(4). 348–357. 39 indexed citations
7.
8.
Bohnacker, Thomas, A.E. Prota, Florent Beaufils, et al.. (2017). Deconvolution of Buparlisib’s mechanism of action defines specific PI3K and tubulin inhibitors for therapeutic intervention. Nature Communications. 8(1). 14683–14683. 86 indexed citations
9.
Beaufils, Florent, Vladimir Cmiljanović, Thomas Bohnacker, et al.. (2017). 5-(4,6-Dimorpholino-1,3,5-triazin-2-yl)-4-(trifluoromethyl)pyridin-2-amine (PQR309), a Potent, Brain-Penetrant, Orally Bioavailable, Pan-Class I PI3K/mTOR Inhibitor as Clinical Candidate in Oncology. Journal of Medicinal Chemistry. 60(17). 7524–7538. 115 indexed citations
10.
Rageot, Denise, Florent Beaufils, Anna Melone, et al.. (2017). Abstract 140: Discovery and biological evaluation of PQR530, a highly potent dual pan-PI3K/mTORC1/2 inhibitor. Cancer Research. 77(13_Supplement). 140–140. 3 indexed citations
11.
Cmiljanović, Vladimir, Robert A. Ettlin, Florent Beaufils, et al.. (2015). Abstract 4514: PQR309: A potent, brain-penetrant, dual pan-PI3K/mTOR inhibitor with excellent oral bioavailability and tolerability. Cancer Research. 75(15_Supplement). 4514–4514. 3 indexed citations
12.
Bohnacker, Thomas, Romina Marone, Janet Dawson, et al.. (2013). Transient targeting of phosphoinositide 3-kinase acts as a roadblock in mast cells' route to allergy. Journal of Allergy and Clinical Immunology. 132(4). 959–968. 24 indexed citations
13.
Barthwal, Manoj Kumar, Joshua J. Anzinger, Qing Xu, et al.. (2013). Fluid-Phase Pinocytosis of Native Low Density Lipoprotein Promotes Murine M-CSF Differentiated Macrophage Foam Cell Formation. PLoS ONE. 8(3). e58054–e58054. 40 indexed citations
14.
Burke, John E., Elena Gogvadze, Thomas Bohnacker, et al.. (2013). PKCβ Phosphorylates PI3Kγ to Activate It and Release It from GPCR Control. PLoS Biology. 11(6). e1001587–e1001587. 52 indexed citations
15.
Schaefer, Thorsten, et al.. (2012). Luminal decoration of blood vessels by activated perivasal mast cells in allergic rhinitis. Allergy. 67(4). 510–520. 3 indexed citations
16.
Anzinger, Joshua J., Janet Chang, Qing Xu, et al.. (2011). Murine bone marrow-derived macrophages differentiated with GM-CSF become foam cells by PI3Kγ-dependent fluid-phase pinocytosis of native LDL. Journal of Lipid Research. 53(1). 34–42. 37 indexed citations
17.
Hochdörfer, Thomas, Rudi W. Hendriks, Bart Vanhaesebroeck, et al.. (2011). Activation of the PI3K pathway increases TLR-induced TNF-α and IL-6 but reduces IL-1β production in mast cells. Cellular Signalling. 23(5). 866–875. 45 indexed citations
18.
Marone, Romina, Thomas Bohnacker, Christian Schnell, et al.. (2009). Targeting Melanoma with Dual Phosphoinositide 3-Kinase/Mammalian Target of Rapamycin Inhibitors. Molecular Cancer Research. 7(4). 601–613. 92 indexed citations
19.
Shymanets, Aliaksei, Thomas Bohnacker, Carsten Brock, et al.. (2009). Ras is an indispensable coregulator of the class I B phosphoinositide 3-kinase p87/p110γ. Proceedings of the National Academy of Sciences. 106(48). 20312–20317. 68 indexed citations
20.
Bohnacker, Thomas, et al.. (2009). PI3Kγ Adaptor Subunits Define Coupling to Degranulation and Cell Motility by Distinct PtdIns(3,4,5)P 3 Pools in Mast Cells. Science Signaling. 2(74). ra27–ra27. 72 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Vladimir Cmiljanović Breakdown of academic impact, for papers by Da-Sheng Wang Breakdown of academic impact, for papers by Danny Tam Breakdown of academic impact, for papers by Anice Moumen Breakdown of academic impact, for papers by Philip Ryan Breakdown of academic impact, for papers by Martin Pass Breakdown of academic impact, for papers by Wells S. Brown Breakdown of academic impact, for papers by Kenneth R. LaMontagne Breakdown of academic impact, for papers by Joachim Bischof Breakdown of academic impact, for papers by Arabel Vollmann‐Zwerenz
Rankless by CCL
2026